Form 4: STERIS plc: Insider Reports Share Transactions
Insider Transaction Report
Julia Madsen, Sr. VP and GM of Life Sciences at STERIS plc, reported a transaction involving the withholding of shares for tax purposes and disclosed beneficial ownership details.
Summary
- Julia Madsen, Sr. VP and GM of Life Sciences at STERIS plc, engaged in a transaction on June 1, 2026.
- 208 ordinary shares were withheld to cover taxes required upon the vesting of 578 restricted shares.
- The vested shares were valued at the NYSE closing market price on June 1, 2026.
- Following this transaction, Madsen beneficially owns 10,502 ordinary shares directly.
- Of the total ordinary shares held, 3,425 are currently restricted, with restrictions lapsing on various dates through June 5, 2028.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard insider transaction related to compensation and tax obligations rather than a significant strategic event or financial performance indicator.
Positives
- Insider transaction indicates continued vesting of restricted shares, a common incentive for management.
- The withholding of shares for taxes is a standard procedure and does not represent a sale of shares by the insider.
- Madsen continues to hold a significant number of shares (10,502) directly, indicating ongoing commitment.
Negatives
- A portion of vested shares (208) were withheld, reducing the immediate net shares received by the insider.
Risks
- The vesting schedule for the remaining 3,425 restricted shares could be impacted by future company performance or employment status.
- Fluctuations in the NYSE closing market price on June 1, 2026, determined the value of withheld shares.
Future Outlook
The filing details the vesting schedule for restricted shares through June 5, 2028, indicating a long-term incentive structure for the reporting person.
Industry Context
StockSavvy.ai notes that Form 4 filings are routine disclosures for publicly traded companies, providing transparency into insider transactions. This specific filing from STERIS plc, a company in the healthcare technology and services sector, reflects standard executive compensation practices involving restricted stock awards and tax management.
Stakeholder Impact
- Shareholders: Increased transparency into insider holdings and compensation practices.
- Employees: Reinforces the incentive structure for key management personnel.
- Management: Standard tax management related to vested equity compensation.
Next Steps
- Monitoring the lapse of restrictions on the remaining 3,425 ordinary shares through June 5, 2028.
- Observing future Form 4 filings for any additional transactions by Julia Madsen or other insiders.
Key Dates
| Date | Description |
|---|---|
| 06/01/2026 | Earliest transaction date and date of share vesting and tax withholding. |
| 06/02/2026 | Date for lapse of restriction on 352 ordinary shares. |
| 06/03/2026 | Date for lapse of restriction on 666 ordinary shares. |
| 06/04/2026 | Date for lapse of restriction on 542 ordinary shares. |
| 06/03/2026 | Date of filing signature. |
| 06/03/2027 | Date for lapse of restriction on 666 ordinary shares. |
| 06/04/2027 | Date for lapse of restriction on 542 ordinary shares. |
| 06/05/2028 | Date for lapse of restriction on 666 ordinary shares. |
Keywords
STERIS plc, STE, Form 4, Insider Transaction, Beneficial Ownership, Restricted Shares, Share Vesting, Tax Withholding, Julia Madsen, Life Sciences
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.